Increasing our options for cancer treatment in Europe

by European Public Health Alliance | Feb 10, 2021 | COVID-19, Non Communicable Diseases (NCDs), Universal Access and Affordable Medicines | Latest Developments

EPHA has joined a number of organisations led by EPHA member the Anticancer Fund calling for the repurposing of various drugs already widely used for non-cancer diseases which have shown promise for the treatment of cancer, allowing new cancer treatments to be...

Should governments consider Roma a priority in their Covid-19 vaccination roll-out plans?

by European Public Health Alliance | Feb 3, 2021 | #VaccineEquity, COVID-19, Roma Health | Analysis and Opinion

Guest article by: Maja Saitovic, Program Officer, Race, Ethnicity and Health Equity team, Open Society Foundations’ Public Health Program; Marek Szilvasi, PhD., Team Manager, Race, Ethnicity and Health Equity team, Open Society Foundations’ Public Health ProgramThe...

Transparency is a fundamental pillar for the success of the EU Vaccines Strategy

by Yannis Natsis | Dec 17, 2020 | COVID-19, Universal Access and Affordable Medicines | Latest Developments

39 civil society organisations including EPHA are calling on the European Commission and EU national governments to ensure a maximum degree of transparency in the EU’s exchanges, negotiations and deals with pharmaceutical companies over COVID19 vaccines, proposing a...

Dear EU Health Ministers, Downgrading EU health action is the wrong answer to the coronavirus crisis

by Rosemary Hindle | Oct 5, 2020 | #EU4Health, COVID-19, Europe and Health

The European Public Health Alliance understands that the European Commission’s EU4health proposal is being drastically cut back by EU Member States, in the ongoing negotiations between EU national governments in the Council of the EU. This risks much less EU...

Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy, say health NGOs

by European Public Health Alliance | Sep 18, 2020 | COVID-19, Universal Access and Affordable Medicines | Latest Developments

The COVID-19 crisis represents an unprecedented challenge for societies in the European Union as well as at a global level. The European vaccines strategy’s Advance Purchase Agreements (APAs) mechanism has been used by the EU to procure vaccines for COVID-19. We...

“It’s time to invest in a healthy future” EPHA joins calls for more EU support for health in the wake of COVID19

by European Public Health Alliance | Sep 9, 2020 | #EU4Health, COVID-19

The European Public Health Alliance, as part of the EU4Health Civil Society Alliance, has joined calls for the European Commission’s new health programme to be based on 10 guiding principlesThe coronavirus outbreak has highlighted the inefficiency and inequity of our...